Whiteside TL - Search Results

1

Clinical Significance of PD-L1⁺ Exosomes in Plasma of Head and Neck Cancer Patients.

Theodoraki MN, Yerneni SS, Hoffmann TK, Gooding WE, Whiteside TL. Theodoraki MN, et al. Among authors: whiteside tl. Clin Cancer Res. 2018 Feb 15;24(4):896-905. doi: 10.1158/1078-0432.CCR-17-2664. Epub 2017 Dec 12. Clin Cancer Res. 2018. PMID: 29233903 Free PMC article.

2

Immunologic effector cells in head and neck cancer.

Vitolo D, Letessier EM, Johnson JT, Whiteside TL. Vitolo D, et al. Among authors: whiteside tl. J Natl Cancer Inst Monogr. 1992;(13):203-8. J Natl Cancer Inst Monogr. 1992. PMID: 1356393

3

The T-cell receptor V beta gene usage in tumor-infiltrating lymphocytes and blood of patients with hepatocellular carcinoma.

Weidmann E, Whiteside TL, Giorda R, Herberman RB, Trucco M. Weidmann E, et al. Among authors: whiteside tl. Cancer Res. 1992 Nov 1;52(21):5913-20. Cancer Res. 1992. PMID: 1382847

4

Receptors for interleukin 2 on human squamous cell carcinoma cell lines and tumor in situ.

Weidmann E, Sacchi M, Plaisance S, Heo DS, Yasumura S, Lin WC, Johnson JT, Herberman RB, Azzarone B, Whiteside TL. Weidmann E, et al. Among authors: whiteside tl. Cancer Res. 1992 Nov 1;52(21):5963-70. Cancer Res. 1992. PMID: 1394222

5

Enrichment in tumor-reactive CD8+ T-lymphocytes by positive selection from the blood and lymph nodes of patients with head and neck cancer.

Letessier EM, Heo DS, Okarma T, Johnson JT, Herberman RB, Whiteside TL. Letessier EM, et al. Among authors: whiteside tl. Cancer Res. 1991 Aug 1;51(15):3891-9. Cancer Res. 1991. PMID: 1677310

6

Immunological effects of treatment with sequential administration of recombinant interferon gamma and alpha in patients with metastatic renal cell carcinoma during a phase I trial.

Ernstoff MS, Gooding W, Nair S, Bahnson RR, Miketic LM, Banner B, Day R, Whiteside T, Titus-Ernstoff L, Kirkwood JM. Ernstoff MS, et al. Cancer Res. 1992 Feb 15;52(4):851-6. Cancer Res. 1992. PMID: 1737346 Clinical Trial.

7

Functional and phenotypic analysis of lymphocytes in head and neck cancer.

Snyderman CH, Heo DS, Johnson JT, D'Amico F, Barnes L, Whiteside TL. Snyderman CH, et al. Among authors: whiteside tl. Arch Otolaryngol Head Neck Surg. 1991 Aug;117(8):899-905. doi: 10.1001/archotol.1991.01870200093016. Arch Otolaryngol Head Neck Surg. 1991. PMID: 1832546

8

Preliminary trial of nonrecombinant interferon alpha in recurrent squamous cell carcinoma of the head and neck.

Vlock DR, Johnson J, Myers E, Day R, Gooding WE, Whiteside T, Pelch K, Sigler B, Wagner R, Colao D, et al. Vlock DR, et al. Head Neck. 1991 Jan-Feb;13(1):15-21. doi: 10.1002/hed.2880130103. Head Neck. 1991. PMID: 1989925

9

Induction of tumor regression in experimental model of human head and neck cancer by human A-LAK cells and IL-2.

Sacchi M, Vitolo D, Sedlmayr P, Rabinowich H, Johnson JT, Herberman RB, Whiteside TL. Sacchi M, et al. Among authors: whiteside tl. Int J Cancer. 1991 Mar 12;47(5):784-91. doi: 10.1002/ijc.2910470527. Int J Cancer. 1991. PMID: 2004859

10

A phase IA trial of sequential administration recombinant DNA-produced interferons: combination recombinant interferon gamma and recombinant interferon alfa in patients with metastatic renal cell carcinoma.

Ernstoff MS, Nair S, Bahnson RR, Miketic LM, Banner B, Gooding W, Day R, Whiteside T, Hakala T, Kirkwood JM. Ernstoff MS, et al. J Clin Oncol. 1990 Oct;8(10):1637-49. doi: 10.1200/JCO.1990.8.10.1637. J Clin Oncol. 1990. PMID: 2120392

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

710 results

Search Page

Filters